This content is machine translated Relvar Ellipta improves asthma control [1]. Asthma control is and remains the non-negotiable therapeutic goal Today, fluticasone furoate is the most potent inhaled corticosteroid (ICS) with the highest therapeutic index available to date [2,3]. It is a component of Relvar Ellipta along with vilanterol. Daley-Yates…
This content is machine translated Podcast Prevention and therapy of respiratory diseases Especially in times of the Corona pandemic, we have learned that prevention is the best therapy of any respiratory infection, because prevention measures do not only apply in the case… CME-Test
This content is machine translated Video Prevention and therapy of respiratory diseases Especially in times of the Corona pandemic, we have learned that prevention is the best therapy of any respiratory infection, because prevention measures do not only apply in the case…
View Post 7 min This content is machine translated A portrait of malignant pleural mesothelioma A disease at its peak Exposure to asbestos until 1990 is taking its toll – including the still-increasing number of malignant pleural mesotheliomas in Switzerland. The life expectancy of those affected is extremely low at…
View Post 3 min This content is machine translated Respiratory Vitamin D brings small benefit In 2017, a meta-analysis of data from 25 randomized controlled trials (RCTs) of vitamin D supplementation for the prevention of acute respiratory infections (ARIs) found a protective effect of this…
View Post 4 min This content is machine translated Non-small cell lung cancer The role of adjuvant EGFR TKIs. Over the past several years, tyrosine kinase inhibitors directed against EGFR have gained acceptance as first-line treatment for advanced NSCLC with EGFR mutation. However, their role in adjuvant therapy of…
View Post 3 min This content is machine translated Severe asthma A switch can be worthwhile – most of the time A proportion of patients with severe eosinophilic bronchial asthma show inadequate effects under IL-5 antibody therapy. Switching to an IL-5 receptor antibody may promise success under certain conditions. A recent…
View Post 4 min This content is machine translated Exogenous allergic alveolitis Don’t play the bagpipes in the Jacuzzi Exogenous allergic alveolitis (EAA) is in itself a very rare disease. So when we talk about common and rare triggers of EAA, we are dealing with very small numbers of…
View Post 3 min This content is machine translated Non-resolving pneumonia When the inflammation does not want to heal Pneumonia remains a common and deadly infectious disease. Nearly 40,000 patients are hospitalized in Switzerland each year for pneumonia, and a good 1,000 people die each year as a result…
View Post 3 min This content is machine translated Idiopathic pulmonary fibrosis Change of therapy often useful Two antifibrotic drugs are currently available for the drug therapy of idiopathic pulmonary fibrosis (IPF): Pirfenidone and the tyrosine kinase inhibitor nintedanib. Therapy intolerances are rare, but do occur. However,…
View Post 6 min This content is machine translated AECOPD Color blind to the use of antibiotics Antibiotics are regularly used in the treatment of COPD patients with acute exacerbations (AECOPD) – too regularly, if you take a look at the guidelines. These recommend its use only…
